ibrutinib news

All news on ibrutinib (also known as Imbruvica): plants, production capacities, investments and involved companies.

26 June 2026

Lilly's Jaypirca recommended by CHMP for EU approval in CLL across all therapy lines

CHMP issued a positive opinion for pirtobrutinib for adults with CLL across all lines of therapy; application now referred to the European Commission for final decision.

Who will be producing ibrutinib in the future?

Find out with chemXplore Alpha

Learn more